Organic Letters
Letter
(8) Arthurs, C. L.; Lingley, K. F.; Piacenti, M.; Stratford, I. J.; Tatic,
T.; Whitehead, R. C.; Wind, N. S. Tetrahedron Lett. 2008, 49, 2410−
2413.
products, the chemical shifts of the key resonances from the A
and B rings match nearly perfectly.
We have synthesized the highly chlorinated ABC tricyclic
ring system of clionastatins A and B in 12 steps from known,
readily available enone 7. We have validated the key Diels−
Alder disconnection to this highly oxidized and chlorinated
steroid and addressed the installation of all three chlorides
found in clionastatin A, which lays the groundwork for a
convergent synthesis of the natural products themselves.
Important aspects of this work include (1) the diastereose-
lectivity of the Diels−Alder cycloaddition of chiral cyclo-
hexenone 7, which should ultimately permit an enantioselective
synthesis of the clionastatins starting from enantioenriched 7,
(2) the remarkable reversal of dichlorination diastereoselectiv-
ity upon cleavage of the silyl ether in 5, and (3) the confidence
gained in Fattorusso’s original structural and stereochemical
assignments of clionastatins A and B. Clearly, the fortuitous
diastereoselective dichlorination reaction of homoallylic alcohol
15 could not have been predicted at the outset, and this work
underscores the empirical nature of the chemical synthesis of
unusual natural products. Work toward the enantioselective
syntheses of 1 and 2 is currently underway and will be reported
in the future.
(9) Symmes, C.; Quin, L. D. J. Org. Chem. 1976, 41, 238−242.
(10) Charest, M. G.; Siegel, D. R.; Myers, A. G. J. Am. Chem. Soc.
2005, 127, 8292−8293.
(11) Jeroncic, L. O.; Cabal, M. P.; Danishefsky, S. J.; Schulte, G. M. J.
Org. Chem. 1991, 56, 387−395.
(12) Wender, P. A.; Kogen, H.; Lee, H. Y.; Munger, J. D., Jr.;
Wilhelm, R. S.; Williams, P. D. J. Am. Chem. Soc. 1989, 111, 8957−
8958.
(13) Noam, M.; Tamir, I.; Breuer, E.; Mechoulam, R. Tetrahedron
1981, 37, 597−604.
(14) Arhart, R. J.; Martin, J. C. J. Am. Chem. Soc. 1972, 94, 5003−
5010.
ASSOCIATED CONTENT
* Supporting Information
■
S
Experimental procedures and spectral data for all new
compounds. This material is available free of charge via the
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the NIH for research support via grant GM-086483
and the NSF for support via a Graduate Research Fellowship to
S.S.T. We are grateful to Hung V. Pham (UCLA) for providing
the minimized structure of clionastatin A in Figure 1 and to Dr.
Allen Hong and Sean Feng (UCI) for assisting in the synthesis
of early intermediates.
REFERENCES
■
(1) For a recent review and good lead reference, see: Nes, W. D.
Chem. Rev. 2011, 111, 6423−6451.
(2) For some representative reviews, see: (a) Groen, M. B.; Zeelen,
F. J. Recl. Trav. Chim. Pays-Bas 1986, 105, 465−48. (b) Zeelen, F. J.
Nat. Prod. Rep. 1994, 11, 607−612. (c) Hanson, J. R. Nat. Prod. Rep.
2010, 27, 887−899. The latter reference is the latest in a series of
reviews covering the partial synthesis of steroids in medicinal
chemistry.
(3) Fattorusso, E.; Taglialatela-Scafati, O.; Petrucci, F.; Bavestrello,
G.; Calcinai, B.; Cerrano, C.; Di Meglio, P.; Ianaro, A. Org. Lett. 2004,
6, 1633−1635.
(4) Chung, W.-j.; Vanderwal, C. D. Acc. Chem. Res. 2014, 47, 718−
728.
(5) Jung, M. E.; Gomez, A. V. Tetrahedron Lett. 1993, 34, 2891−
2894.
(6) Yoder, R. A.; Johnston, J. N. Chem. Rev. 2005, 105, 4730−4756.
(7) Stoltz, B. M.; Kano, T.; Corey, E. J. J. Am. Chem. Soc. 2000, 122,
9044−9045.
1461
dx.doi.org/10.1021/ol500265v | Org. Lett. 2014, 16, 1458−1461